Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. | Sci Adv | 2022 | 35921418 | PubTator, text mining | PubMed |
| Surgical management in immunosuppressed patients with sigmoid diverticulitis, still a challenge: a single-center observational study. | Int J Colorectal Dis | 2022 | 35918442 | PubTator, text mining | PubMed |
| BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity. | J Immunol Res | 2022 | 35915658 | PubTator, text mining | PubMed |
| Cross-Activation of Hemichannels/Gap Junctions and Immunoglobulin-Like Domains in Innate-Adaptive Immune Responses. | Front Immunol | 2022 | 35911693 | PubTator, text mining | PubMed |
| THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer. | Dis Markers | 2022 | 35909893 | PubTator, text mining | PubMed |
| Neuroinflammation: Extinguishing a blaze of T cells. | Immunol Rev | 2022 | 35909230 | PubTator, text mining | PubMed |
| Radiotherapy combined with immunotherapy: the dawn of cancer treatment. | Signal Transduct Target Ther | 2022 | 35906199 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer. | Front Pharmacol | 2022 | 35903347 | PubTator, text mining | PubMed |
| Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. | Front Immunol | 2022 | 35903099 | PubTator, text mining | PubMed |
| Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. | Stem Cell Res Ther | 2022 | 35902958 | PubTator, text mining | PubMed |
| Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines. | Oncoimmunology | 2022 | 35898703 | PubTator, text mining | PubMed |
| Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer. | Front Immunol | 2022 | 35898507 | PubTator, text mining | PubMed |
| Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies. | Stem Cell Rev Rep | 2022 | 35896860 | PubTator, text mining | PubMed |
| Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments. | Elife | 2022 | 35894206 | PubTator, text mining | PubMed |
| Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions. | Int J Mol Sci | 2022 | 35887000 | PubTator, text mining | PubMed |
| The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma-Recent Findings and Review. | Biomedicines | 2022 | 35884974 | PubTator, text mining | PubMed |
| Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung Cancer. | Biomedicines | 2022 | 35884843 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms. | Cancers (Basel) | 2022 | 35884612 | PubTator, text mining | PubMed |
| A 'Hybrid' Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy. | Cancers (Basel) | 2022 | 35884565 | PubTator, text mining | PubMed |
| Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils. | Cancers (Basel) | 2022 | 35884427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=54